They said it was sold at a 30% premium, so that would make it valued at roughly $0.30 CPS previously.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025